Black Diamond Therapeutics, Inc. Common Stock vs. Kymera Therapeutics, Inc. Common Stock
BDTX
Black Diamond Therapeutics, Inc. Common Stock
$2.03 +2.53%
VS KYMRKymera Therapeutics, Inc. Common Stock
$130.07 +1.52%
Kymera Therapeutics, Inc. Common Stock (KYMR) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BDTX | KYMR | |
|---|---|---|
| Market Cap | $113.76 million | $10.94 billion |
| Revenue (TTM) | — | — |
| Net Income (TTM) | $-42,555,000 | — |
KYMR leads on 1 of 1 size & scale factors.
Valuation
| BDTX | KYMR | |
|---|---|---|
| Price / Book | 1.18 | — |
BDTX and KYMR split the valuation factors evenly.
Profitability
| BDTX | KYMR | |
|---|---|---|
| Return on Equity | -44.29% | — |
BDTX and KYMR split the profitability factors evenly.
Risk & Sentiment
| BDTX | KYMR | |
|---|---|---|
| Short Interest | 2.27% | 0.23% |
KYMR leads on 1 of 1 risk & sentiment factors.
Dig deeper: BDTX overview, BDTX financials, KYMR overview, KYMR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.